Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Rapid method for screening of both calcium and magnesium chelation with comparison of 21 known metal chelators

L. Konečný, Z. Lomozová, G. Karabanovich, J. Roh, K. Vávrová, P. Mladěnka

. 2024 ; 29 (7-8) : 785-800. [pub] 20241018

Language English Country Germany

Document type Journal Article, Comparative Study

Grant support
CZ.02.01.01/00/22_008/0004607 NETPHARM
SVV 260 663 Charles University

Chelation is the rational treatment modality in metal overload conditions, but chelators are often non-selective and can, hence, cause an imbalance in the homeostasis of physiological metals including calcium and magnesium. The aim of this study was to develop an affordable, rapid but sensitive and precise method for determining the degree of chelation of calcium and magnesium ions and to employ this method for comparison on a panel of known metal chelators. Spectrophotometric method using o-cresolphthalein complexone (o-CC) was developed and its biological relevance was confirmed in human platelets by impedance aggregometry. The lowest detectable concentration of calcium and magnesium ions by o-CC was 2.5 μM and 2 μM, respectively. The indicator was stable for at least 110 days. Four and seven out of twenty-one chelators strongly chelated calcium and magnesium ions, respectively. Importantly, the chelation effect of clinically used chelators was not negligible. Structure-activity relationships for eight quinolin-8-ols showed improvements in chelation particularly in the cases of dihalogen substitution, and a negative linear relationship between pKa and magnesium chelation was observed. Calcium chelation led to inhibition of platelet aggregation in concentrations corresponding to the complex formation. A novel method for screening of efficacy and safety of calcium and magnesium ion chelation was developed and validated.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003211
003      
CZ-PrNML
005      
20250206104152.0
007      
ta
008      
250121s2024 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00775-024-02078-6 $2 doi
035    __
$a (PubMed)39422739
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Konečný, Lukáš $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, 50003, Hradec Králové, Czechia
245    10
$a Rapid method for screening of both calcium and magnesium chelation with comparison of 21 known metal chelators / $c L. Konečný, Z. Lomozová, G. Karabanovich, J. Roh, K. Vávrová, P. Mladěnka
520    9_
$a Chelation is the rational treatment modality in metal overload conditions, but chelators are often non-selective and can, hence, cause an imbalance in the homeostasis of physiological metals including calcium and magnesium. The aim of this study was to develop an affordable, rapid but sensitive and precise method for determining the degree of chelation of calcium and magnesium ions and to employ this method for comparison on a panel of known metal chelators. Spectrophotometric method using o-cresolphthalein complexone (o-CC) was developed and its biological relevance was confirmed in human platelets by impedance aggregometry. The lowest detectable concentration of calcium and magnesium ions by o-CC was 2.5 μM and 2 μM, respectively. The indicator was stable for at least 110 days. Four and seven out of twenty-one chelators strongly chelated calcium and magnesium ions, respectively. Importantly, the chelation effect of clinically used chelators was not negligible. Structure-activity relationships for eight quinolin-8-ols showed improvements in chelation particularly in the cases of dihalogen substitution, and a negative linear relationship between pKa and magnesium chelation was observed. Calcium chelation led to inhibition of platelet aggregation in concentrations corresponding to the complex formation. A novel method for screening of efficacy and safety of calcium and magnesium ion chelation was developed and validated.
650    _2
$a lidé $7 D006801
650    12
$a hořčík $x chemie $7 D008274
650    12
$a vápník $x analýza $x metabolismus $7 D002118
650    12
$a chelátory $x chemie $7 D002614
650    _2
$a agregace trombocytů $x účinky léků $7 D010974
650    _2
$a trombocyty $x účinky léků $x metabolismus $7 D001792
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a preklinické hodnocení léčiv $x metody $7 D004353
655    _2
$a časopisecké články $7 D016428
655    _2
$a srovnávací studie $7 D003160
700    1_
$a Lomozová, Zuzana $u Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy in Hradec Králové, Charles University, 50003, Hradec Králové, Czechia
700    1_
$a Karabanovich, Galina $u Department of Organic and Bioorganic Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, 50003, Hradec Králové, Czechia
700    1_
$a Roh, Jaroslav $u Department of Organic and Bioorganic Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, 50003, Hradec Králové, Czechia
700    1_
$a Vávrová, Kateřina $u Department of Organic and Bioorganic Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, 50003, Hradec Králové, Czechia
700    1_
$a Mladěnka, Přemysl $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, 50003, Hradec Králové, Czechia. mladenkap@faf.cuni.cz $1 https://orcid.org/0000000260766900 $7 xx0233006
773    0_
$w MED00005752 $t JBIC, Journal of biological inorganic chemistry $x 1432-1327 $g Roč. 29, č. 7-8 (2024), s. 785-800
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39422739 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104148 $b ABA008
999    __
$a ok $b bmc $g 2263139 $s 1239218
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 29 $c 7-8 $d 785-800 $e 20241018 $i 1432-1327 $m JBIC, Journal of biological inorganic chemistry $n J Biol Inorg Chem $x MED00005752
GRA    __
$a CZ.02.01.01/00/22_008/0004607 $p NETPHARM
GRA    __
$a SVV 260 663 $p Charles University
LZP    __
$a Pubmed-20250121

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...